US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 71.710
  • +0.190+0.27%
Close Apr 26 16:00 ET
  • 72.250
  • +0.540+0.75%
Post 18:48 ET
3.41BMarket Cap-13607P/E (TTM)

Axsome Therapeutics Key Stats

Axsome Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 6, 2024

Revenue(YoY)

73.04M

-22.77%
EPS(YoY)

-1.22

-368.99%

Strong Buy

Apr 28, 2024

Axsome Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 87.626M--
May 6, 20242024/Q1-- / 73.041M--
Feb 20, 20242023/Q471.531M / 69.036M--
Nov 6, 20232023/Q357.794M / 54.860M--
Aug 7, 20232023/Q246.700M / 40.948M--
May 8, 20232023/Q194.576M / 26.319M--
Feb 27, 20232022/Q424.372M / 21.748M--
Nov 7, 20222022/Q316.846M / 17.057M--
Aug 9, 20222022/Q28.820M / 6.919M--
May 2, 20222022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 87.626M--
May 6, 20242024/Q1-- / 73.041M--
Feb 20, 20242023/Q471.531M / 69.036M--
Nov 6, 20232023/Q357.794M / 54.860M--
Aug 7, 20232023/Q246.700M / 40.948M--
May 8, 20232023/Q194.576M / 26.319M--
Feb 27, 20232022/Q424.372M / 21.748M--
Nov 7, 20222022/Q316.846M / 17.057M--
Aug 9, 20222022/Q28.820M / 6.919M--
May 2, 20222022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Axsome Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 28, 2024

Strong Buy

  • Buy

    91.67%
  • Hold

    8.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg